Viewing StudyNCT00214565



Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00214565
Status: TERMINATED
Last Update Posted: 2010-11-19
First Post: 2005-09-20

Brief Title: GALLANT 6 Tesaglitazar vs Pioglitazone
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
Type 2 diabetes View